Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 190.58
-8.42 (-4.23%)
Jul 21, 2025, 1:44 PM CST
Beijing Hotgen Biotech Company Description
Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.
It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins.
Beijing Hotgen Biotech Co., Ltd. was founded in 2005 and is based in Beijing, China.
Beijing Hotgen Biotech Co., Ltd.
| Country | China |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 903 |
| CEO | Changqing Lin |
Contact Details
Address: Zhongguancun High-end Medical Device Ind Beijing, 102629 China | |
| Website | hotgen.com.cn |
Stock Details
| Ticker Symbol | 688068 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003P82 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Changqing Lin | Chairman and GM |
| Zhongchao Jie | Financial Director and Accounting Supervisor |
| Yanzhao Li | Deputy GM and Director |
| Yongzhan Shi | Deputy GM, Secretary and Director |
| Xiaochi Jie | Deputy General Manager |
| Lida Xu | Chairman of the Supervisory Board and Research & Development Director Bioinformatics Center |